These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 35323718)
1. Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse. Correia B; Fernandes J; Botica MJ; Ferreira C; Quintas A Medicines (Basel); 2022 Mar; 9(3):. PubMed ID: 35323718 [TBL] [Abstract][Full Text] [Related]
2. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Miliano C; Serpelloni G; Rimondo C; Mereu M; Marti M; De Luca MA Front Neurosci; 2016; 10():153. PubMed ID: 27147945 [TBL] [Abstract][Full Text] [Related]
3. An overview of New Psychoactive Substances (NPS) in northeast Brazil: NMR-based identification and analysis of ecstasy tablets by GC-MS. Cunha RL; Oliveira CDSL; de Oliveira AL; Maldaner AO; do Desterro Cunha S; Pereira PAP Forensic Sci Int; 2023 Mar; 344():111597. PubMed ID: 36801502 [TBL] [Abstract][Full Text] [Related]
4. Khat and synthetic cathinones: a review. Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389 [TBL] [Abstract][Full Text] [Related]
5. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature. Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131 [No Abstract] [Full Text] [Related]
6. Synthetic cathinones: an evolving class of new psychoactive substances. Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318 [TBL] [Abstract][Full Text] [Related]
8. Synthetic drugs of abuse. Tamama K Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850 [TBL] [Abstract][Full Text] [Related]
9. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic. Lo Faro AF; Berardinelli D; Cassano T; Dendramis G; Montanari E; Montana A; Berretta P; Zaami S; Busardò FP; Huestis MA Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829550 [TBL] [Abstract][Full Text] [Related]
10. Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives. Radaelli D; Manfredi A; Zanon M; Fattorini P; Scopetti M; Neri M; Frisoni P; D'Errico S Curr Neuropharmacol; 2021; 19(11):2038-2048. PubMed ID: 33845747 [TBL] [Abstract][Full Text] [Related]
11. Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances. Rodrigues CHP; Mariotto LS; Castro JS; Peruquetti PH; Silva-Junior NC; Bruni AT Forensic Toxicol; 2023 Jul; 41(2):187-212. PubMed ID: 36604359 [TBL] [Abstract][Full Text] [Related]
12. Next generation of novel psychoactive substances on the horizon - A complex problem to face. Zawilska JB; Andrzejczak D Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089 [TBL] [Abstract][Full Text] [Related]
13. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Palamar JJ; Martins SS; Su MK; Ompad DC Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051 [TBL] [Abstract][Full Text] [Related]
14. Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act. Webb NE; Wood DM; Greene SL; Hunter LJ; Archer JRH; Dines AM; Dargan PI Clin Toxicol (Phila); 2019 Jan; 57(1):36-41. PubMed ID: 30067112 [TBL] [Abstract][Full Text] [Related]
15. Motivations for new psychoactive substance use among regular psychostimulant users in Australia. Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577 [TBL] [Abstract][Full Text] [Related]
16. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019. Crulli B; Dines AM; Blanco G; Giraudon I; Eyer F; Liechti ME; Miró Ò; Hovda KE; Heyerdahl F; Yates C; Vallersnes OM; Wood DM; Dargan PI; Clin Toxicol (Phila); 2022 Dec; 60(12):1318-1327. PubMed ID: 36322684 [TBL] [Abstract][Full Text] [Related]